Physician profile
Benjamin L Smith
NPI 1760721146
$926.12
in general payments reported to CMS, 2019-2025
12 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $148 · 2022: $229 · 2023: $284 · 2024: $149 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $199.23 | 2021-2025 | Euflexxa |
| Abbott Laboratories | $196.49 | 2022-2023 | Octrode, Proclaim |
| Bioventus LLC | $130.23 | 2023-2024 | Exogen Ultrasound Bone Healing System, Supartz Fx Sodium Hyaluronate, Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $92.31 | 2021-2022 | |
| Depuy Synthes Sales INC. | $84.48 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $50.42 | 2024-2025 | Zilretta, Iovera, Exparel |
| Orthofix Medical, INC. | $44.04 | 2022-2025 | Physio-Stim |
| Smith+Nephew, INC. | $36.49 | 2022-2025 | Pico |
| Regeneron Healthcare Solutions, INC. | $32.80 | 2025 | Dupixent |
| Endo USA, INC. | $23.32 | 2024 | Xiaflex |
| Glaxosmithkline, LLC. | $19.23 | 2021 | |
| Acumed LLC | $17.08 | 2024 | Inframe Implant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.